Equities

Kontafarma China Holdings Ltd

Kontafarma China Holdings Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (HKD)0.031
  • Today's Change-0.002 / -6.06%
  • Shares traded42.00k
  • 1 Year change-20.51%
  • Beta0.4365
Data delayed at least 15 minutes, as of Sep 20 2024 08:48 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of HKD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments88143184
Total Receivables, Net365379402
Total Inventory116153171
Prepaid expenses2.163.045.82
Other current assets, total171219
Total current assets588690781
Property, plant & equipment, net5748011,110
Goodwill, net253301359
Intangibles, net250268278
Long term investments35424.70
Note receivable - long term13----
Other long term assets121826
Total assets1,7272,1202,559
LIABILITIES
Accounts payable6.672139
Accrued expenses263824
Notes payable/short-term debt000
Current portion long-term debt/capital leases106223307
Other current liabilities, total245222333
Total current liabilities384505703
Total long term debt228368422
Total debt334591729
Deferred income tax405567
Minority interest4.6655146
Other liabilities, total133629
Total liabilities6701,0191,367
SHAREHOLDERS EQUITY
Common stock111111
Additional paid-in capital1,5241,5241,524
Retained earnings (accumulated deficit)(432)(404)(362)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total(45)(30)19
Total equity1,0571,1011,192
Total liabilities & shareholders' equity1,7272,1202,559
Total common shares outstanding5,5895,5895,589
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.